These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27372154)

  • 1. Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection.
    Gouma S; Ten Hulscher HI; Schurink-van 't Klooster TM; de Melker HE; Boland GJ; Kaaijk P; van Els CACM; Koopmans MPG; van Binnendijk RS
    Vaccine; 2016 Jul; 34(35):4166-4171. PubMed ID: 27372154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sera from different age cohorts in Belgium show limited cross-neutralization between the mumps vaccine and outbreak strains.
    Vermeire T; Barbezange C; Francart A; Hamouda A; Litzroth A; Hutse V; Martens L; Vandermarliere E; Van Gucht S
    Clin Microbiol Infect; 2019 Jul; 25(7):907.e1-907.e6. PubMed ID: 30502489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood.
    Rasheed MAU; Hickman CJ; McGrew M; Sowers SB; Mercader S; Hopkins A; Grimes V; Yu T; Wrammert J; Mulligan MJ; Bellini WJ; Rota PA; Orenstein WA; Ahmed R; Edupuganti S
    Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19071-19076. PubMed ID: 31481612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak.
    Rubin SA; Qi L; Audet SA; Sullivan B; Carbone KM; Bellini WJ; Rota PA; Sirota L; Beeler J
    J Infect Dis; 2008 Aug; 198(4):508-15. PubMed ID: 18558869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Third Dose of Measles-Mumps-Rubella Vaccine to Improve Immunity Against Mumps in Young Adults.
    Kaaijk P; Wijmenga-Monsuur AJ; van Houten MA; Veldhuijzen IK; Ten Hulscher HI; Kerkhof J; van der Klis FR; van Binnendijk RS
    J Infect Dis; 2020 Mar; 221(6):902-909. PubMed ID: 31112277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China.
    Cui A; Zhu Z; Mao N; Si Y; Ma Y; Hu Y; Deng X; Wang L; Zeng L; Zhang Y; Xu W
    Vaccine; 2018 Sep; 36(38):5725-5731. PubMed ID: 30122648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mumps-specific IgG, IgG subclasses and neutralization titres to the vaccine and outbreak mumps strains differ in vaccinated healthy controls, breakthrough mumps infection cases and naturally infected individuals.
    Foley DJ; Connell AR; Gonzalez G; Connell J; Leahy TR; De Gascun C; Hassan J
    J Clin Virol; 2022 Dec; 157():105296. PubMed ID: 36209622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mumps outbreaks in a highly vaccinated population: Investigation of a neutralization titre against the current circulating wildtype genotype G5 mumps virus.
    Kenny L; O'Kelly E; Connell J; De Gascun C; Hassan J
    J Clin Virol; 2016 Jan; 74():8-12. PubMed ID: 26630067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity.
    Cortese MM; Barskey AE; Tegtmeier GE; Zhang C; Ngo L; Kyaw MH; Baughman AL; Menitove JE; Hickman CJ; Bellini WJ; Dayan GH; Hansen GR; Rubin S
    J Infect Dis; 2011 Nov; 204(9):1413-22. PubMed ID: 21933874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of Mumps Virus Genotype G Vaccine Candidates in Jeryl Lynn-Immunized Mice.
    Briggs K; Kirby C; Beavis AC; Zengel J; Patil P; Sauder C; He B
    J Virol; 2022 Apr; 96(8):e0198321. PubMed ID: 35389265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-neutralization between vaccine and circulating wild-type mumps viruses in Korea.
    Won H; Kim AR; Yoo JS; Chung GT; Kang HJ; Kim SJ; Kim SS; Lee JW
    Vaccine; 2021 Mar; 39(13):1870-1876. PubMed ID: 33642163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age.
    Haralambieva IH; Ovsyannikova IG; Kennedy RB; Goergen KM; Grill DE; Chen MH; Hao L; Icenogle J; Poland GA
    Vaccine; 2020 Jan; 38(5):1249-1257. PubMed ID: 31732325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial.
    Nakayama T; Eda M; Hirano M; Goto W
    Hum Vaccin Immunother; 2019; 15(5):1139-1144. PubMed ID: 30724658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults.
    Fiebelkorn AP; Coleman LA; Belongia EA; Freeman SK; York D; Bi D; Kulkarni A; Audet S; Mercader S; McGrew M; Hickman CJ; Bellini WJ; Shivakoti R; Griffin DE; Beeler J
    J Infect Dis; 2016 Apr; 213(7):1115-23. PubMed ID: 26597262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.
    Rafiei Tabatabaei S; Esteghamati AR; Shiva F; Fallah F; Radmanesh R; Abdinia B; Shamshiri AR; Khairkhah M; Shekari Ebrahimabad H; Karimi A
    Arch Iran Med; 2013 Jan; 16(1):38-41. PubMed ID: 23273235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rubella virus neutralizing antibody response after a third dose of measles-mumps-rubella vaccine in young adults.
    McLean HQ; Fiebelkorn AP; Ogee-Nwankwo A; Hao L; Coleman LA; Adebayo A; Icenogle JP
    Vaccine; 2018 Sep; 36(38):5732-5737. PubMed ID: 30107992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Virus strain specific serum neutralizing antibodies in children and adolescents immunized with a Russian mumps vaccine].
    Otrashevskaia EV; Krasil'nikov IV; Ignat'ev GM
    Vopr Virusol; 2010; 55(6):15-9. PubMed ID: 21381334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mumps: MMR vaccination and genetic diversity of mumps virus, 2007-2011 in Catalonia, Spain.
    Barrabeig I; Antón A; Torner N; Pumarola T; Costa J; Domínguez À;
    BMC Infect Dis; 2019 Nov; 19(1):954. PubMed ID: 31706275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Use of an Endpoint Titration Assay To Characterize Mumps IgG Avidity following Measles, Mumps, and Rubella Vaccination and Wild-Type Mumps Infection.
    Mercader S; McGrew M; Sowers SB; Williams NJ; Bellini WJ; Hickman CJ
    mSphere; 2018 Sep; 3(5):. PubMed ID: 30209129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-neutralization between three mumps viruses & mapping of haemagglutinin-neuraminidase (HN) epitopes.
    Vaidya SR; Dvivedi GM; Jadhav SM
    Indian J Med Res; 2016 Jan; 143(1):37-42. PubMed ID: 26997012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.